Clifford Chance advises ESTEVE on its binding offer for the acquisition of HRA Pharma Rare Diseases

by Clifford Chance

Clifford Chance has advised global pharmaceutical company ESTEVE on the acquisition from self-care products provider Perrigo Company of HRA Pharma Rare Diseases, a France-based company specialised in ...

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

Xcalibur Smart Mapping strengthens its g...

by MCH Private Equity

​Xcalibur Smart Mapping, recognised as the global leader in airborne...

Photos Stream